• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内 C 形磁驱动系统引导药物中断血流增强溶栓。

Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C-Shaped Magnetic Actuation System In Vivo.

机构信息

Department of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Shanghai, 200233, P. R. China.

Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, 199 Ren'ai Road, Suzhou, Jiangsu, 215123, P. R. China.

出版信息

Adv Mater. 2021 Dec;33(51):e2105351. doi: 10.1002/adma.202105351. Epub 2021 Oct 13.

DOI:10.1002/adma.202105351
PMID:34647345
Abstract

Fast and effective thrombolysis using tissue plasminogen activator (tPA) is limited by the poor delivery efficiency of thrombolytic drugs, which is induced by an interrupted bloodstream and delayed recanalization. Existing magnetic micro/nanodrug-loaded robots used for targeted thrombotic therapy are limited by the complexity of the clinical verification of nanodrugs and the limited space of magnetic actuation systems. Herein, a general drug delivery strategy based on mass transportation theory for thrombolysis is presented, and an open space C-shaped magnetic actuation system with laser location and ultrasound imaging navigation for in vivo evaluation is developed. tPA can be guided through an interrupted bloodstream to the thrombi by the locomotion of magnetic nanoparticle swarms (MNSs), thereby improving the thrombolysis efficacy. Notably, this strategy is able to quickly establish a life channel to achieve time-critical recanalization, which is typically inaccessible using native tPA. Both in vitro and in vivo thrombolysis experiments demonstrate that the thrombus lysis efficacy significantly increases after the application of the MNS under a rotating magnetic field. This study provides an anticipated C-shaped magnetic actuation system for in vivo validation and also presents a clinically feasible drug delivery strategy for targeted thrombolytic therapy with minimal systemic tPA exposure.

摘要

利用组织型纤溶酶原激活物(tPA)进行快速有效的溶栓治疗受到溶栓药物输送效率低下的限制,这是由于血流中断和再通延迟所致。现有的用于靶向血栓治疗的磁性微/纳米载药机器人受到纳米药物临床验证的复杂性和磁驱动系统空间有限的限制。在此,提出了一种基于质量输运理论的溶栓通用药物输送策略,并开发了一种具有激光定位和超声成像导航的开放式 C 形磁驱动系统,用于体内评估。通过磁纳米颗粒群(MNS)的运动,tPA 可以穿过血流中断到达血栓,从而提高溶栓效果。值得注意的是,该策略能够快速建立生命通道,实现时间关键的再通,而这通常是使用天然 tPA 无法实现的。体外和体内溶栓实验表明,在旋转磁场下应用 MNS 后,血栓溶解效果显著提高。本研究为体内验证提供了一种预期的 C 形磁驱动系统,也为具有最小全身 tPA 暴露的靶向溶栓治疗提供了一种临床可行的药物输送策略。

相似文献

1
Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C-Shaped Magnetic Actuation System In Vivo.体内 C 形磁驱动系统引导药物中断血流增强溶栓。
Adv Mater. 2021 Dec;33(51):e2105351. doi: 10.1002/adma.202105351. Epub 2021 Oct 13.
2
Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.肽和重组组织型纤溶酶原激活物偶联聚乳酸-羟基乙酸共聚物(PLGA)磁性纳米颗粒的制备及其用于双重靶向溶栓治疗。
Int J Mol Sci. 2020 Apr 13;21(8):2690. doi: 10.3390/ijms21082690.
3
In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.在兔股动脉血栓模型中使用负载组织纤溶酶原激活剂的靶向微泡进行体内溶栓
J Thromb Thrombolysis. 2014 Jul;38(1):57-64. doi: 10.1007/s11239-014-1071-8.
4
Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.使用负载组织型纤溶酶原激活剂的回声脂质体进行超声辅助溶栓。
Thromb Res. 2007;119(6):777-84. doi: 10.1016/j.thromres.2006.06.009. Epub 2006 Aug 2.
5
A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.一种新型的静脉冠状动脉溶栓药物输送系统,具有血栓靶向和超声可恢复的隐身活性。
J Am Coll Cardiol. 2012 Dec 18;60(24):2550-7. doi: 10.1016/j.jacc.2012.08.1008. Epub 2012 Nov 14.
6
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.一种纤维蛋白原模拟物,激活血小板敏感的纳米凝聚体增强组织型纤溶酶原激活剂的血栓靶向和穿透作用,实现有效的溶栓治疗。
Adv Healthc Mater. 2022 Oct;11(19):e2201265. doi: 10.1002/adhm.202201265. Epub 2022 Jul 31.
7
Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.靶向纳米递药策略促进缺血性脑卒中的溶栓治疗。
Drug Deliv. 2021 Dec;28(1):357-371. doi: 10.1080/10717544.2021.1879315.
8
Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.通过与硅涂层磁纳米颗粒结合实现组织型纤溶酶原激活剂的靶向递送。
Int J Nanomedicine. 2012;7:5137-49. doi: 10.2147/IJN.S36197. Epub 2012 Sep 27.
9
Novel and emerging therapies: thrombus-targeted fibrinolysis.新型和新兴疗法:血栓靶向纤维蛋白溶解。
Semin Thromb Hemost. 2013 Feb;39(1):48-58. doi: 10.1055/s-0032-1328935. Epub 2012 Oct 3.
10
Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.载有 rtPA 的基于 Fe₃O₄ 的 PLGA 纳米粒子的构建和评价用于血栓的检测和靶向溶栓。
ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5566-76. doi: 10.1021/am406008k. Epub 2014 Apr 2.

引用本文的文献

1
Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy.用于调节缺血性心肌病治疗的纳米医学进展。
Mater Today Bio. 2025 Aug 23;34:102238. doi: 10.1016/j.mtbio.2025.102238. eCollection 2025 Oct.
2
Multiscale physics-based modelling of nanocarrier-assisted intravascular drug delivery.基于多尺度物理的纳米载体辅助血管内药物递送建模
Front Drug Deliv. 2024 Mar 4;4:1362660. doi: 10.3389/fddev.2024.1362660. eCollection 2024.
3
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
用于基于热疗的治疗和可控药物递送的磁性纳米材料。
Bioact Mater. 2025 Jul 26;53:591-629. doi: 10.1016/j.bioactmat.2025.07.033. eCollection 2025 Nov.
4
Technology Roadmap of Micro/Nanorobots.微纳机器人技术路线图
ACS Nano. 2025 Jul 15;19(27):24174-24334. doi: 10.1021/acsnano.5c03911. Epub 2025 Jun 27.
5
Micro/nanorobots in antimicrobial therapy: Addressing challenges of antibiotic resistance.抗菌治疗中的微纳机器人:应对抗生素耐药性挑战
Mater Today Bio. 2025 May 31;32:101936. doi: 10.1016/j.mtbio.2025.101936. eCollection 2025 Jun.
6
Untethered miniature robots for minimally invasive thrombus treatment: From bench to clinical trials.用于微创血栓治疗的无系留微型机器人:从实验台到临床试验。
Innovation (Camb). 2025 Mar 11;6(6):100874. doi: 10.1016/j.xinn.2025.100874. eCollection 2025 Jun 2.
7
Endogenous Near-Infrared Chemiluminescence: Imaging-Guided Non-Invasive Thrombolysis and Anti-Inflammation Based on a Heteronuclear Transition Metal Complex.内源性近红外化学发光:基于异核过渡金属配合物的成像引导无创溶栓与抗炎作用
Adv Sci (Weinh). 2025 May;12(19):e2501257. doi: 10.1002/advs.202501257. Epub 2025 Mar 26.
8
Rapid Blood Clot Removal via Remote Delamination and Magnetization of Clot Debris.通过血块碎片的远程分层和磁化实现快速血块清除。
Adv Sci (Weinh). 2025 May;12(17):e2415305. doi: 10.1002/advs.202415305. Epub 2025 Mar 8.
9
Emerging Elastic Micro-Nano Materials for Diagnosis and Treatment of Thrombosis.用于血栓诊断与治疗的新型弹性微纳材料
Research (Wash D C). 2025 Feb 28;8:0614. doi: 10.34133/research.0614. eCollection 2025.
10
Magnetically driven bionic nanorobots enhance chemotherapeutic efficacy and the tumor immune response via precise targeting.磁驱动仿生纳米机器人通过精确靶向提高化疗疗效和肿瘤免疫反应。
Innovation (Camb). 2025 Jan 18;6(2):100777. doi: 10.1016/j.xinn.2024.100777. eCollection 2025 Feb 3.